No Data
No Data
Accuray's CyberKnife System Shows Disease Control, Safety in NEJM Study
Accuray Announced That Results Of The Pace-B– Prostate Advances In Comparative Evidence – Trial Were Published In The New England Journal Of Medicine
New England Journal of Medicine Study Reaffirms Five Session Radiation Treatment Provides Comparable Rates of Cancer Control, Tolerability and Sexual Functioning to Conventional Radiotherapy Treatment in Men With Localized Prostate Cancer
Press Release: Accuray President and Chief Executive Officer Suzanne Winter Returns From Medical Leave of Absence
Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife S7 System Medical Professional Training
Accuray | 10-K: FY2024 Annual Report